Description
Cell-Free DNA (cfDNA) Markets details the market opportunity for cfDNA analysis instruments, consumables, kits, and related software. The report provides complete market information, including current market estimates and forecasts to 2021, as well as:
- Growth Rate for cfDNA Market, 2016-2021
- cfDNA Clinical Diagnostics Market, 2016-2021
- cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021
- cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
- cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems, Services)
- Market Share by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2016
The report provides information on cfDNA analysis products, commenting not only on reagents, consumables, kits, systems, software, and services, but also on oncology cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.
In the cfDNA market there are many technical challenges to overcome, along with a range of competitive, regulatory, and IP issues. Cancer is a dynamic and defiant disease. While NIPT is a proven application, oncology will require much more difficult work and is more uncertain. The variety of potential issues and threats in the market are covered in the challenges and strategic recommendations chapter of the report. The competitive situation, deals, and litigation are covered in respective chapters as well.
Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services. The report profiles those companies competing in the cfDNA instruments and consumables market, including:
- Agilent Technologies
- Bio-Rad
- F. Hoffmann-La Roche AG
- Fluidigm
- Illumina
- Qiagen
- RainDance Technologies
- Thermo Fisher Scientific
The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
NIPT, Oncology Leading Market Forward
Sensitivity Benefits of dPCR, qPCR, NGS
Challenges, Biological and Technologies Limitations
Scope and Methodology
CHAPTER TWO: INTRODUCTION
NIPT Companies, Others Shifting Strategies to Cancer
Expanding Clinical Adoption Sustains High Growth
Government Initiatives — Cancer Moonshot, Blood Profiling Atlas
Mergers, Acquisitions, Equity Investments Increasing
China Becoming Major Player in Market
Personalized, Proactive Medicine Gaining Momentum
Expected Sequencer Platforms Stalled or Cancelled
Significant Efforts in Automation, Miniaturization
Regulatory Situation Unclear But Evolving Somewhat
CHAPTER THREE: CFDNA PRODUCTS
cfDNA Reagents, Consumables, and Kits
cfDNA Systems and Software
cfDNA NIPT Products and Services
cfDNA in Oncology, Transplantation and Other Diseases
cfDNA Other Products
Recent Product/ Service Introductions
2016
2015
CHAPTER FOUR: MARKET SIZE AND SHARE ANALYSIS
Revenues Forecast
Market Size and Forecast
cfDNA Clinical Diagnostics Market
cfDNA Market by Region
Revenues by Product Type
Illumina Sequencing Revenues as Indicator
CHAPTER FIVE: CORPORATE PROFILES
Agilent Technologies
- Hoffmann-La Roche AG
Fluidigm
Illumina
Qiagen
RainDance Technologies
Thermo Fisher Scientific
Chapter 6: Challenges and Strategic Recommendations
Challenges
Strategic Recommendations
List of Exhibits
Chapter 3: cfDNA Analysis Products
Table 3-1: cfDNA Reagents, Consumables, and Kits
Table 3-2: cfDNA Systems and Software
Table 3-3: cfDNA NIPT Products and Services
Table 3-4: Oncology cfDNA Products
Table 3-5: cfDNA Transplantation Diagnostics
Table 3-6: cfDNA Other Products
Chapter 4: Market Analysis
Figure 4-1: Cost of Sequencing a Genome
Table 4-1: Market for cfDNA
Figure 4-2: cfDNA Market, 2015-2021
Table 4-2: Growth Rate for cfDNA Market, 2015-2021
Figure 4-3: Growth Rate in cfDNA Market, 2016-2020
Table 4-3: cfDNA Clinical Diagnostics Market, 2015-2021
Table 4-4: cfDNA Clinical Diagnostics Market Growth Rate, 2015-2021
Table 4-5: cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
Figure 4-4: cfDNA Market by Region, 2015 (%) (N. America, Europe, Asia-Pacific & ROW)
Table 4-6: cfDNA Instruments and Consumables Revenues by Product Type,2015 (Consumables, Systems/hardware, Services)
Figure 4-5: Breakout of cfDNA Market by Type, 2015 (%) (Consumables,Systems/hardware, Services)
Table 4-7: Illumina Quarterly Sequencing Revenues (2012-2016)
Figure 4-6: Illumina Quarterly Consumables Revenues (2012-2016)
Table 4-8: Illumina Annual Consumables Revenues (2012-2015)
Table 4-9: Illumina Consumables Growth Rates (2013-2015)
Chapter 7: cfDNA Analysis Market Deals
Table 7-1: cfDNA Analysis Market Deals
